首页 > 最新文献

Biomedica : revista del Instituto Nacional de Salud最新文献

英文 中文
Presence of integrons and their correlation with multidrug resistance in Salmonella enterica serovar Typhimurium: Exploratory systematic review 整合子的存在及其与鼠伤寒沙门氏菌多重耐药性的相关性:探索性系统综述。
Pub Date : 2024-05-30 DOI: 10.7705/biomedica.6816
Nancy Yaneth Flórez, Claudia Silva, José Miguel Villarreal, Magdalena Wiesner

In Salmonella enterica serovar Typhimurium (Typhimurium), multidrug resistance is associated with integrons carrying resistance genes dispersed by mobile genetic elements. This exploratory systematic review sought to identify integron types and their resistance genes in multidrug resistance Typhimurium isolates. We used Medline, PubMed, SciELO, ScienceDirect, Redalyc, and Google Scholar as motor searchers for articles in Spanish or English published between 2012 and 2020, including the keywords “integrons”, “antibiotic resistance”, and “Salmonella Typhimurium”. We included 38 articles reporting multidrug resistance up to five antibiotic families.Class 1 integrons with aadA2 and blaPSE-1 gene cassettes were predominant, some probably related to the Salmonella genomic island 1. We did not find studies detailing class 1 and 2 integrons in the same isolate, nor class 3 integrons reported. The presence of integrons largely explains the resistance profiles found in isolates from different sources in 15 countries.

伤寒沙门氏菌(Typhimurium)的抗生素多重耐药性与携带耐药基因的整合子有关,这些整合子通过移动遗传因子扩散。在这一探索性系统综述中,我们试图确定耐多药伤寒沙门氏菌分离物中整合子的类型及其耐药基因。我们在 Medline、PubMed、SciELO、ScienceDirect、Redalyc 和 Google Scholar 上检索了 2012 年至 2020 年间发表的英文或西班牙文文章,关键词为 "整合子"、"抗生素耐药性 "和 "鼠伤寒沙门氏菌"。分析共纳入了38篇报道对5个抗生素家族产生多重耐药性的文章。带有 aadA2 和 blaPSE-1 基因盒的 1 类整合子占多数,其中一些可能与沙门氏菌基因组岛 1 有关。在同一分离物中没有发现 1 类和 2 类整合子,也没有 3 类整合子的报道。整合子的存在在很大程度上解释了在来自 15 个国家不同来源的分离物中发现的抗药性特征。
{"title":"Presence of integrons and their correlation with multidrug resistance in Salmonella enterica serovar Typhimurium: Exploratory systematic review","authors":"Nancy Yaneth Flórez, Claudia Silva, José Miguel Villarreal, Magdalena Wiesner","doi":"10.7705/biomedica.6816","DOIUrl":"10.7705/biomedica.6816","url":null,"abstract":"<p><p>In Salmonella enterica serovar Typhimurium (Typhimurium), multidrug resistance is associated with integrons carrying resistance genes dispersed by mobile genetic elements. This exploratory systematic review sought to identify integron types and their resistance genes in multidrug resistance Typhimurium isolates. We used Medline, PubMed, SciELO, ScienceDirect, Redalyc, and Google Scholar as motor searchers for articles in Spanish or English published between 2012 and 2020, including the keywords “integrons”, “antibiotic resistance”, and “Salmonella Typhimurium”. We included 38 articles reporting multidrug resistance up to five antibiotic families.\u0000Class 1 integrons with aadA2 and blaPSE-1 gene cassettes were predominant, some probably related to the Salmonella genomic island 1. We did not find studies detailing class 1 and 2 integrons in the same isolate, nor class 3 integrons reported. The presence of integrons largely explains the resistance profiles found in isolates from different sources in 15 countries.</p>","PeriodicalId":101322,"journal":{"name":"Biomedica : revista del Instituto Nacional de Salud","volume":"44 2","pages":"258-276"},"PeriodicalIF":0.0,"publicationDate":"2024-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11374117/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141877205","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Survival analysis and associated factors of highgrade glioma patients 高级别胶质瘤患者的生存分析和相关因素。
Pub Date : 2024-05-30 DOI: 10.7705/biomedica.6742
Lina Marcela Barrera, Leon Darío Ortiz, Hugo de Jesús Grisales, Mauricio Camargo

Introduction: High-grade gliomas are the most common primary brain tumors in adults, and they usually have a quick fatal course. Average survival is 18 months, mainly, because of tumor resistance to Stupp protocol.

Objective: To determine high-grade glioma patient survival and the effect of persuasion variables on survival.

Materials and methods: We conducted a longitudinal descriptive study in which 80 untreated recently diagnosed high-grade glioma patients participated. A survey was conducted regarding their exposure to some risk factors, degree of genetic instability in peripheral blood using micronucleus quantification on binuclear lymphocytes, micronuclei in reticulocytes and sister-chromatid exchanges in lymphocytes. In the statistical analysis, this study constructed life tables, used the Kaplan-Meier, and the log-rank test, and in the multivariate analysis, a Cox proportional hazards model was constructed.

Results: Eighty patients' clinical, demographic and lifestyle characteristics were analyzed, as well as their survival rates and the average survival time is 784 days (interquartile range: 928). Factors like age, exposure at work to polycyclic hydrocarbons and the number of sister-chromatid exchanges in lymphocytes in the first sampling was significantly survivalrelated in the multivariate analysis.

Conclusion: We determined that only three of the analyzed variables have an important effect on survival time when it comes to high-grade glioma patients.

导言高级别胶质瘤是成人中最常见的原发性脑肿瘤,其病程通常很快。平均生存期为 18 个月,这主要是因为肿瘤对 Stupp 方案有抵抗力:目的:确定高级别胶质瘤患者的生存率以及说服变量对生存率的影响:我们进行了一项纵向描述性研究,80 名未经治疗的新近确诊的高级别胶质瘤患者参加了研究。调查内容包括患者接触的一些风险因素、外周血中的遗传不稳定程度(使用双核淋巴细胞微核定量法)、网状细胞中的微核以及淋巴细胞中的姐妹染色单体交换。在统计分析中,本研究构建了生命表,使用了 Kaplan-Meier 和对数秩检验,在多变量分析中,构建了 Cox 比例危险模型:结果:分析了 80 名患者的临床、人口统计学和生活方式特征,以及他们的存活率,平均存活时间为 784 天(四分位数间距:928)。在多变量分析中,年龄、工作中接触多环碳氢化合物的情况以及第一次取样时淋巴细胞中姐妹染色单体交换的数量等因素与存活率有显著相关性:我们确定,在分析的变量中,只有三个变量对高级别胶质瘤患者的存活时间有重要影响。
{"title":"Survival analysis and associated factors of highgrade glioma patients","authors":"Lina Marcela Barrera, Leon Darío Ortiz, Hugo de Jesús Grisales, Mauricio Camargo","doi":"10.7705/biomedica.6742","DOIUrl":"10.7705/biomedica.6742","url":null,"abstract":"<p><strong>Introduction: </strong>High-grade gliomas are the most common primary brain tumors in adults, and they usually have a quick fatal course. Average survival is 18 months, mainly, because of tumor resistance to Stupp protocol.</p><p><strong>Objective: </strong>To determine high-grade glioma patient survival and the effect of persuasion variables on survival.</p><p><strong>Materials and methods: </strong>We conducted a longitudinal descriptive study in which 80 untreated recently diagnosed high-grade glioma patients participated. A survey was conducted regarding their exposure to some risk factors, degree of genetic instability in peripheral blood using micronucleus quantification on binuclear lymphocytes, micronuclei in reticulocytes and sister-chromatid exchanges in lymphocytes. In the statistical analysis, this study constructed life tables, used the Kaplan-Meier, and the log-rank test, and in the multivariate analysis, a Cox proportional hazards model was constructed.</p><p><strong>Results: </strong>Eighty patients' clinical, demographic and lifestyle characteristics were analyzed, as well as their survival rates and the average survival time is 784 days (interquartile range: 928). Factors like age, exposure at work to polycyclic hydrocarbons and the number of sister-chromatid exchanges in lymphocytes in the first sampling was significantly survivalrelated in the multivariate analysis.</p><p><strong>Conclusion: </strong>We determined that only three of the analyzed variables have an important effect on survival time when it comes to high-grade glioma patients.</p>","PeriodicalId":101322,"journal":{"name":"Biomedica : revista del Instituto Nacional de Salud","volume":"44 2","pages":"191-206"},"PeriodicalIF":0.0,"publicationDate":"2024-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11374120/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141877209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
When air became public domain 当空气成为公共领域时
Pub Date : 2024-05-30 DOI: 10.7705/biomedica.7552
Luis Jorge Hernández-Flórez
{"title":"When air became public domain","authors":"Luis Jorge Hernández-Flórez","doi":"10.7705/biomedica.7552","DOIUrl":"10.7705/biomedica.7552","url":null,"abstract":"","PeriodicalId":101322,"journal":{"name":"Biomedica : revista del Instituto Nacional de Salud","volume":"44 2","pages":"132-134"},"PeriodicalIF":0.0,"publicationDate":"2024-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11232487/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141877165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Potentially inappropriate medication on communitydwelling older adults: Longitudinal analysis using the International Mobility in Aging Study. 对居住在社区的老年人的潜在不当用药:利用国际老龄流动性研究进行纵向分析。
Pub Date : 2024-05-30 DOI: 10.7705/biomedica.6992
Edison Pineda, Alejandra Fernández, Carmen Lucía Curcio, Juliana Fernandes de Souza, Afshin Vafaei, José Fernando Gómez

Introduction: Medications are a fundamental part of the treatment of multiple pathologies. However, despite their benefits, some are considered potentially inappropriate medications for older people given their safety profile. Epidemiological data differences related to potentially inappropriate medications make it difficult to determine their effects on elderly people.

Objective: To estimate the prevalence and types of potentially inappropriate medications using the 2019 Beers Criteria® in a cohort of adults older than 65 years.

Materials and methods: We performed an observational, multicenter, retrospective, longitudinal study of a four-year follow-up of potentially inappropriate medications in community-dwelling older adults.

Results: We followed 820 participants from five cities for four years (2012-2016) and evaluated them in three different moments (m1 = 2012, m2 = 2014, and m3 = 2016). The average age was 69.07 years, and 50.9% were women. The potentially inappropriate medication prevalence in the participants was 40.24%. The potentially inappropriate medications' mean among the studied subjects in the first moment was 1.65 (SD = 0.963), in the second was 1.73 (SD = 1.032), and in the third was 1.62 (SD = 0.915). There were no statistical differences between measurements (Friedman test, value = 0.204). The most frequent potentially inappropriate medications categories were gastrointestinal (39.4%), analgesics (18.8%), delirium-related drugs (15.4%), benzodiazepines (15.2%), and cardiovascular (14.2%).

Conclusions: About half of the population of the community-dwelling older adults had prescriptions of potentially inappropriate medications in a sustained manner and without significant variability over time. Mainly potentially inappropriate medications were gastrointestinal and cardiovascular drugs, analgesics, delirium-related drugs, and benzodiazepines.

引言药物是治疗多种疾病的基本要素。然而,尽管药物有其益处,但鉴于其安全性,有些药物被认为可能不适合老年人使用。由于潜在不适当药物的流行病学数据存在差异,因此很难确定其对老年人的影响:使用 2019 Beers Criteria® 估计 65 岁以上成年人队列中潜在不适当药物的流行率和类型:我们对居住在社区的老年人的潜在用药不当情况进行了为期四年的观察性、多中心、回顾性、纵向研究:我们对来自五个城市的 820 名参与者进行了为期四年(2012-2016 年)的随访,并在三个不同的时间段(m1 = 2012 年、m2 = 2014 年和 m3 = 2016 年)对他们进行了评估。参与者的平均年龄为 69.07 岁,50.9% 为女性。参与者的潜在用药不当率为 40.24%。研究对象的潜在不当用药平均值在第一时刻为 1.65(SD = 0.963),第二时刻为 1.73(SD = 1.032),第三时刻为 1.62(SD = 0.915)。不同测量之间没有统计学差异(Friedman 检验,值 = 0.204)。最常见的潜在不当药物类别是胃肠道药物(39.4%)、镇痛药(18.8%)、谵妄相关药物(15.4%)、苯二氮卓类药物(15.2%)和心血管药物(14.2%):在社区居住的老年人中,约有一半的人持续开具潜在的不适当药物处方,且随着时间的推移变化不大。可能不适当的药物主要是胃肠道和心血管药物、镇痛药、谵妄相关药物和苯二氮卓类药物。
{"title":"Potentially inappropriate medication on communitydwelling older adults: Longitudinal analysis using the International Mobility in Aging Study.","authors":"Edison Pineda, Alejandra Fernández, Carmen Lucía Curcio, Juliana Fernandes de Souza, Afshin Vafaei, José Fernando Gómez","doi":"10.7705/biomedica.6992","DOIUrl":"10.7705/biomedica.6992","url":null,"abstract":"<p><strong>Introduction: </strong>Medications are a fundamental part of the treatment of multiple pathologies. However, despite their benefits, some are considered potentially inappropriate medications for older people given their safety profile. Epidemiological data differences related to potentially inappropriate medications make it difficult to determine their effects on elderly people.</p><p><strong>Objective: </strong>To estimate the prevalence and types of potentially inappropriate medications using the 2019 Beers Criteria® in a cohort of adults older than 65 years.</p><p><strong>Materials and methods: </strong>We performed an observational, multicenter, retrospective, longitudinal study of a four-year follow-up of potentially inappropriate medications in community-dwelling older adults.</p><p><strong>Results: </strong>We followed 820 participants from five cities for four years (2012-2016) and evaluated them in three different moments (m1 = 2012, m2 = 2014, and m3 = 2016). The average age was 69.07 years, and 50.9% were women. The potentially inappropriate medication prevalence in the participants was 40.24%. The potentially inappropriate medications' mean among the studied subjects in the first moment was 1.65 (SD = 0.963), in the second was 1.73 (SD = 1.032), and in the third was 1.62 (SD = 0.915). There were no statistical differences between measurements (Friedman test, value = 0.204). The most frequent potentially inappropriate medications categories were gastrointestinal (39.4%), analgesics (18.8%), delirium-related drugs (15.4%), benzodiazepines (15.2%), and cardiovascular (14.2%).</p><p><strong>Conclusions: </strong>About half of the population of the community-dwelling older adults had prescriptions of potentially inappropriate medications in a sustained manner and without significant variability over time. Mainly potentially inappropriate medications were gastrointestinal and cardiovascular drugs, analgesics, delirium-related drugs, and benzodiazepines.</p>","PeriodicalId":101322,"journal":{"name":"Biomedica : revista del Instituto Nacional de Salud","volume":"44 2","pages":"207-216"},"PeriodicalIF":0.0,"publicationDate":"2024-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11314927/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141877204","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of resistance to macrolides and aminoglycosides in Mycobacterium avium, M. abscessus, and M. chelonae identified in the Laboratorio Nacional de Referencia of Colombia from 2018 to 2022 2018年至2022年期间哥伦比亚国家参考实验室发现的分枝杆菌和脓肿分枝杆菌复合体以及螯合分枝杆菌对大环内酯类和氨基糖苷类药物耐药性的流行情况。
Pub Date : 2024-05-30 DOI: 10.7705/biomedica.7197
Claudia Llerena, Yanely Angélica Valbuena, Angie Paola Zabaleta, Angélica Nathalia García

Introduction: The Mycobacterium chelonae species and the M. avium and M. abscessus complexes are emerging pathogens that cause mycobacteriosis. Treatment depends on the species and subspecies identified. The drugs of choice are macrolides and aminoglycosides. However, due to the resistance identified to these drugs, determining the microbe’s sensitivity profile will allow clinicians to improve the understanding of the prognosis and evolution of these pathologies.

Objective: To describe the macrolide and aminoglycoside susceptibility profile of cultures identified by Colombia’s Laboratorio Nacional de Referencia de Mycobacteria from 2018 to 2022, as Mycobacterium avium complex, M. abscessus complex, and M. chelonae.Materials and methods. This descriptive study exposes the susceptibility profile to macrolides and aminoglycosides of cultures identified as M. avium complex, M. abscessus complex, and M. chelonae using the GenoType® NTM-DR method.

Materials and methods: This descriptive study exposes the susceptibility profile to macrolides and aminoglycosides of cultures identified as M. avium complex, M. abscessus complex, and M. chelonae using the GenoType® NTM-DR method.

Results: We identified 159 (47.3 %) cultures as M. avium complex, of which 154 (96.9 %) were sensitive to macrolides, and 5 (3.1 %) were resistant; all were sensitive to aminoglycosides. From the 125 (37.2 %) cultures identified as M. abscessus complex, 68 (54.4 %) were sensitive to macrolides, 57 (45.6 %) were resistant to aminoglycosides, and just one (0.8 %) showed resistance to aminoglycosides. The 52 cultures (15.5 %) identified as M. chelonae were sensitive to macrolides and aminoglycosides.

Conclusions: The three studied species of mycobacteria have the least resistance to Amikacin. Subspecies identification and their susceptibility profiles allow the establishment of appropriate treatment schemes, especially against M. abscessus.

导言。螯合分枝杆菌、禽分枝杆菌和脓肿分枝杆菌复合体是导致分枝杆菌病的新病原体。对这种感染的治疗取决于所确定的菌种和亚种。大环内酯类和氨基糖苷类药物是首选药物,但也有耐药性的报道;因此,确定敏感性谱可让治疗医生更好地了解这些感染的预后和演变情况。目的:描述 2018 年至 2022 年期间,在国家分枝杆菌参考实验室(National Reference Laboratory for Mycobacteria)鉴定为复合分枝杆菌、复合脓肿分枝杆菌或切罗纳分枝杆菌的培养物的大环内酯类和氨基糖苷类药物敏感性谱。材料与方法。使用 GenoType® NTM-DR 方法对鉴定为复合鸟疫霉菌、复合脓肿霉菌或切罗纳霉菌的培养物的大环内酯类和氨基糖苷类药物敏感性概况进行了描述性研究。结果:复合鸟疫霉菌培养物有 159 株(47.3%),其中 154 株(96.9%)对大环内酯类药物敏感,5 株(3.1%)耐药;所有培养物对氨基糖苷类药物敏感。在脓肿霉菌复合体中,研究了 125 份(37.2%)培养物,其中 68 份(54.4%)对大环内酯类药物敏感,57 份(45.6%)对大环内酯类药物耐药;只有一份培养物(0.8%)对氨基糖苷类药物耐药。在克氏霉菌中,检测了 52 个培养物(15.5%),它们都对大环内酯类和氨基糖苷类药物敏感:结论:在所研究的三种分枝杆菌中,对阿米卡星耐药的情况最少。通过鉴定亚种和敏感性特征,可以确定适当的治疗方案,尤其是在由脓肿霉菌引起的分枝杆菌病中。
{"title":"Prevalence of resistance to macrolides and aminoglycosides in Mycobacterium avium, M. abscessus, and M. chelonae identified in the Laboratorio Nacional de Referencia of Colombia from 2018 to 2022","authors":"Claudia Llerena, Yanely Angélica Valbuena, Angie Paola Zabaleta, Angélica Nathalia García","doi":"10.7705/biomedica.7197","DOIUrl":"10.7705/biomedica.7197","url":null,"abstract":"<p><strong>Introduction: </strong>The Mycobacterium chelonae species and the M. avium and M. abscessus complexes are emerging pathogens that cause mycobacteriosis. Treatment depends on the species and subspecies identified. The drugs of choice are macrolides and aminoglycosides. However, due to the resistance identified to these drugs, determining the microbe’s sensitivity profile will allow clinicians to improve the understanding of the prognosis and evolution of these pathologies.</p><p><strong>Objective: </strong>To describe the macrolide and aminoglycoside susceptibility profile of cultures identified by Colombia’s Laboratorio Nacional de Referencia de Mycobacteria from 2018 to 2022, as Mycobacterium avium complex, M. abscessus complex, and M. chelonae.\u0000Materials and methods. This descriptive study exposes the susceptibility profile to macrolides and aminoglycosides of cultures identified as M. avium complex, M. abscessus complex, and M. chelonae using the GenoType® NTM-DR method.</p><p><strong>Materials and methods: </strong>This descriptive study exposes the susceptibility profile to macrolides and aminoglycosides of cultures identified as M. avium complex, M. abscessus complex, and M. chelonae using the GenoType® NTM-DR method.</p><p><strong>Results: </strong>We identified 159 (47.3 %) cultures as M. avium complex, of which 154 (96.9 %) were sensitive to macrolides, and 5 (3.1 %) were resistant; all were sensitive to aminoglycosides. From the 125 (37.2 %) cultures identified as M. abscessus complex, 68 (54.4 %) were sensitive to macrolides, 57 (45.6 %) were resistant to aminoglycosides, and just one (0.8 %) showed resistance to aminoglycosides. The 52 cultures (15.5 %) identified as M. chelonae were sensitive to macrolides and aminoglycosides.</p><p><strong>Conclusions: </strong>The three studied species of mycobacteria have the least resistance to Amikacin. Subspecies identification and their susceptibility profiles allow the establishment of appropriate treatment schemes, especially against M. abscessus.</p>","PeriodicalId":101322,"journal":{"name":"Biomedica : revista del Instituto Nacional de Salud","volume":"44 2","pages":"182-190"},"PeriodicalIF":0.0,"publicationDate":"2024-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11329272/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141877206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vitamin D: Synthesis, deficiency, polymorphisms and resistance to its action in Latin American countries 维生素 D:拉丁美洲国家维生素 D 的合成、缺乏、多态性和抗药性
Pub Date : 2024-03-31 DOI: 10.7705/biomedica.7477
Pedro Nel Rueda-Plata
{"title":"Vitamin D: Synthesis, deficiency, polymorphisms and resistance to its action in Latin American countries","authors":"Pedro Nel Rueda-Plata","doi":"10.7705/biomedica.7477","DOIUrl":"10.7705/biomedica.7477","url":null,"abstract":"","PeriodicalId":101322,"journal":{"name":"Biomedica : revista del Instituto Nacional de Salud","volume":"44 1","pages":"5-9"},"PeriodicalIF":0.0,"publicationDate":"2024-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11114286/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140874360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gabriel Toro González 加布里埃尔-托罗-冈萨雷斯
Gustavo Román-Campos, Lydia Isabel Navarro de Román, Mauricio Pérez
{"title":"Gabriel Toro González","authors":"Gustavo Román-Campos, Lydia Isabel Navarro de Román, Mauricio Pérez","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":101322,"journal":{"name":"Biomedica : revista del Instituto Nacional de Salud","volume":"44 1","pages":"119-127"},"PeriodicalIF":0.0,"publicationDate":"2024-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140874012","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Seroprevalence of Trypanosoma cruzi among children from Veracruz, Mexico: Epidemiological baseline for a control model based on Chagas disease active transmission 墨西哥韦拉克鲁斯州儿童的克鲁斯锥虫血清流行率:基于恰加斯病主动传播的控制模型的流行病学基线
Pub Date : 2024-03-31 DOI: 10.7705/biomedica.7126
Ernesto Pérez-Sánchez, Raúl Montiel-Cruz, Eréndira Romero-Domínguez, Griselda Pascacio-Bermúdez, Arturo Báez-Hernández, Guadalupe Díaz Del Castillo-Flores, Fabián Correa-Morales, Gonzalo Vázquez-Prokopec, Pablo Manrique-Saide, Azael Che-Mendoza, Gabriela Meneses-Ruiz, Irma López-Martínez, María Jesús Sánchez

Introduction. In 2021, the Secretaría de Salud de México and the Pan American Health Organization launched an initiative to interrupt intra-domiciliary vector transmission of Trypanosoma cruzi based on the prevalence of Chagas disease in children. The Mexican State of Veracruz was leading this initiative.Objective. To estimate the seroprevalence of T. cruzi infection among children under 15 years of age from rural areas of Veracruz, México.Materials and methods. We identified eight localities of high priority from the Municipality of Tempoal, Veracruz, for baseline serology. Blood samples were collected on filter paper from 817 individuals between June and August 2017, for screening with a third-generation enzyme immunoassay. Reactive cases were confirmed by indirect hemagglutination, enzyme-linked immunosorbent assay, and indirect immunofluorescence tests on peripheral blood serum samples. We calculated seroprevalence and 95% confidence intervals (CI).Results. We confirmed Chagas disease cases in children under 15 years of age with a seroprevalence of 1,9% (95 % CI = 1,12-3,16) in the localities of Citlaltepetl, Cornizuelo, Cruz de Palma and Rancho Nuevo.Conclusions. These results indicate recent transmission of T. cruzi in these communities and allow to establish an epidemiological baseline for the design and implementation of a model focused on geographical areas with active transmission to advance toward the elimination of intra-domiciliary vector transmission of this parasite in Mexico.

导言。2021 年,墨西哥卫生部(Secretaría de Salud de México)和泛美卫生组织(Pan American Health Organization)根据恰加斯病在儿童中的流行情况,发起了一项旨在阻断恰加斯病病媒内部传播的倡议。墨西哥韦拉克鲁斯州是该倡议的牵头州。估算墨西哥韦拉克鲁斯州农村地区 15 岁以下儿童的克鲁兹锥虫病血清感染率。我们在韦拉克鲁斯州滕波尔市确定了八个重点地区进行血清学基线检测。2017 年 6 月至 8 月间,我们用滤纸采集了 817 人的血样,并使用第三代酶免疫测定法进行筛查。通过对外周血血清样本进行间接血凝试验、酶联免疫吸附试验和间接免疫荧光试验,确认了反应性病例。我们计算了血清流行率和 95% 的置信区间 (CI)。我们在 Citlaltepetl、Cornizuelo、Cruz de Palma 和 Rancho Nuevo 等地确诊了 15 岁以下儿童恰加斯病病例,血清流行率为 1.9%(95% CI = 1.12-3.16)。这些结果表明,这些社区最近出现了克鲁斯绦虫的传播,因此可以建立流行病学基线,以便设计和实施一种以传播活跃的地理区域为重点的模式,从而在墨西哥消除这种寄生虫的宿主病媒内传播。
{"title":"Seroprevalence of Trypanosoma cruzi among children from Veracruz, Mexico: Epidemiological baseline for a control model based on Chagas disease active transmission","authors":"Ernesto Pérez-Sánchez, Raúl Montiel-Cruz, Eréndira Romero-Domínguez, Griselda Pascacio-Bermúdez, Arturo Báez-Hernández, Guadalupe Díaz Del Castillo-Flores, Fabián Correa-Morales, Gonzalo Vázquez-Prokopec, Pablo Manrique-Saide, Azael Che-Mendoza, Gabriela Meneses-Ruiz, Irma López-Martínez, María Jesús Sánchez","doi":"10.7705/biomedica.7126","DOIUrl":"10.7705/biomedica.7126","url":null,"abstract":"<p><p>Introduction. In 2021, the Secretaría de Salud de México and the Pan American Health Organization launched an initiative to interrupt intra-domiciliary vector transmission of Trypanosoma cruzi based on the prevalence of Chagas disease in children. The Mexican State of Veracruz was leading this initiative.\u0000Objective. To estimate the seroprevalence of T. cruzi infection among children under 15 years of age from rural areas of Veracruz, México.\u0000Materials and methods. We identified eight localities of high priority from the Municipality of Tempoal, Veracruz, for baseline serology. Blood samples were collected on filter paper from 817 individuals between June and August 2017, for screening with a third-generation enzyme immunoassay. Reactive cases were confirmed by indirect hemagglutination, enzyme-linked immunosorbent assay, and indirect immunofluorescence tests on peripheral blood serum samples. We calculated seroprevalence and 95% confidence intervals (CI).\u0000Results. We confirmed Chagas disease cases in children under 15 years of age with a seroprevalence of 1,9% (95 % CI = 1,12-3,16) in the localities of Citlaltepetl, Cornizuelo, Cruz de Palma and Rancho Nuevo.\u0000Conclusions. These results indicate recent transmission of T. cruzi in these communities and allow to establish an epidemiological baseline for the design and implementation of a model focused on geographical areas with active transmission to advance toward the elimination of intra-domiciliary vector transmission of this parasite in Mexico.</p>","PeriodicalId":101322,"journal":{"name":"Biomedica : revista del Instituto Nacional de Salud","volume":"44 1","pages":"92-101"},"PeriodicalIF":0.0,"publicationDate":"2024-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11204380/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140875114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Newborn screening in Colombia: The experience of a private program in Bogotá 哥伦比亚的新生儿筛查:波哥大私人项目的经验
Pub Date : 2024-03-31 DOI: 10.7705/biomedica.6911
Jaime E Bernal, Martha Lucía Tamayo, Ignacio Briceño, Escilda Benavides

Introduction. The first neonatal screening program in Colombia – PREGEN – was set up in the medical private sector of Bogotá in 1988. We report the results from recent years that, given the scarcity of similar information in our country, may help estimate the frequency of the evaluated neonatal disorders and which ones should be included in the neonatal screening programs in our country.Objective. To describe the results of PREGEN´s newborn screening program between 2006 and 2019.Materials and methods. We analyzed databases and other informative documents preserved in PREGEN from the 2006-2019 period.Results. One in every 164 newborns screened in our program had an abnormal hemoglobin variant, and one in every 194 carried some hemoglobin S variant. Glucose-6-phosphate dehydrogenase deficiency and congenital hypothyroidism are next as the more common disorders.Conclusions. Abnormal hemoglobin causes the most frequent monogenic disorder in the world. Glucose-6-phosphate dehydrogenase deficiency is the most common enzymopathy affecting nearly 400 million individuals worldwide. Since both disorders are more common in people of African descent and confer some resistance to malaria, we believe that screening for both disorders may be more relevant in the areas with African ancestry in our country.

导言。哥伦比亚的第一个新生儿筛查项目--PREGEN--于 1988 年在波哥大的私营医疗机构中设立。鉴于我国缺乏类似信息,我们报告了近年来的结果,这可能有助于估计所评估的新生儿疾病的频率,以及哪些疾病应纳入我国的新生儿筛查计划。描述 2006 年至 2019 年间 PREGEN 新生儿筛查项目的结果。我们分析了 PREGEN 保存的 2006-2019 年间的数据库和其他信息文件。在我们的项目中,每 164 个接受筛查的新生儿中就有一个血红蛋白变异异常,每 194 个新生儿中就有一个携带某种血红蛋白 S 变异。其次是葡萄糖-6-磷酸脱氢酶缺乏症和先天性甲状腺功能减退症。血红蛋白异常是世界上最常见的单基因疾病。葡萄糖-6-磷酸脱氢酶缺乏症是最常见的酶病,影响全球近4亿人。由于这两种疾病在非洲人后裔中更为常见,而且会对疟疾产生一定的抵抗力,因此我们认为在我国的非洲裔地区对这两种疾病进行筛查可能更有意义。
{"title":"Newborn screening in Colombia: The experience of a private program in Bogotá","authors":"Jaime E Bernal, Martha Lucía Tamayo, Ignacio Briceño, Escilda Benavides","doi":"10.7705/biomedica.6911","DOIUrl":"10.7705/biomedica.6911","url":null,"abstract":"<p><p>Introduction. The first neonatal screening program in Colombia – PREGEN – was set up in the medical private sector of Bogotá in 1988. We report the results from recent years that, given the scarcity of similar information in our country, may help estimate the frequency of the evaluated neonatal disorders and which ones should be included in the neonatal screening programs in our country.\u0000Objective. To describe the results of PREGEN´s newborn screening program between 2006 and 2019.\u0000Materials and methods. We analyzed databases and other informative documents preserved in PREGEN from the 2006-2019 period.\u0000Results. One in every 164 newborns screened in our program had an abnormal hemoglobin variant, and one in every 194 carried some hemoglobin S variant. Glucose-6-\u0000phosphate dehydrogenase deficiency and congenital hypothyroidism are next as the more common disorders.\u0000Conclusions. Abnormal hemoglobin causes the most frequent monogenic disorder in the world. Glucose-6-phosphate dehydrogenase deficiency is the most common enzymopathy affecting nearly 400 million individuals worldwide. Since both disorders are more common in people of African descent and confer some resistance to malaria, we believe that screening for both disorders may be more relevant in the areas with African ancestry in our country.</p>","PeriodicalId":101322,"journal":{"name":"Biomedica : revista del Instituto Nacional de Salud","volume":"44 1","pages":"102-107"},"PeriodicalIF":0.0,"publicationDate":"2024-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11210979/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140856478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oral mucormycosis associated with COVID-19 and diabetes mellitus: Case report and literature review 与COVID-19和糖尿病相关的口腔黏液瘤病:病例报告和文献综述
Pub Date : 2024-03-31 DOI: 10.7705/biomedica.6970
Julio César Velasco, Ledmar Jovanny Vargas, Lorena García, Iván José Torres, Iván Camilo González

Mucormycosis is an invasive opportunistic fungal infection with high mortality, mainly detected in people with COVID-19, especially those with underlying diseases such as diabetes mellitus. Mucormycosis prevalence is 0.005 to 1.7 cases per million inhabitants, and it has been increasing in countries like India and Pakistan. This mycosis can affect different organs, and clinical manifestations reflect the transmission mechanism. Frequent forms are rhino-orbital-cerebral and pulmonary. This disease should be suspected in patients with necrotic injuries on mucous membranes or skin.We present a case of a patient with diabetes mellitus and diagnosed with oral mucormycosis associated with COVID-19.

粘孢子菌病是一种侵入性机会真菌感染,死亡率很高,主要见于 COVID-19 患者,尤其是患有糖尿病等基础疾病的患者。粘孢子菌病的发病率为每百万居民 0.005 至 1.7 例,在印度和巴基斯坦等国家呈上升趋势。这种真菌病可影响不同的器官,临床表现反映了传播机制。常见的表现形式有鼻眶-大脑和肺部。粘膜或皮肤上有坏死性损伤的患者应怀疑患有这种疾病。我们报告了一例糖尿病患者的病例,该患者被诊断为与 COVID-19 相关的口腔粘孢子菌病。
{"title":"Oral mucormycosis associated with COVID-19 and diabetes mellitus: Case report and literature review","authors":"Julio César Velasco, Ledmar Jovanny Vargas, Lorena García, Iván José Torres, Iván Camilo González","doi":"10.7705/biomedica.6970","DOIUrl":"10.7705/biomedica.6970","url":null,"abstract":"<p><p>Mucormycosis is an invasive opportunistic fungal infection with high mortality, mainly detected in people with COVID-19, especially those with underlying diseases such as diabetes mellitus. Mucormycosis prevalence is 0.005 to 1.7 cases per million inhabitants, and it has been increasing in countries like India and Pakistan. This mycosis can affect different organs, and clinical manifestations reflect the transmission mechanism. Frequent forms are rhino-orbital-cerebral and pulmonary. This disease should be suspected in patients with necrotic injuries on mucous membranes or skin.\u0000We present a case of a patient with diabetes mellitus and diagnosed with oral mucormycosis associated with COVID-19.</p>","PeriodicalId":101322,"journal":{"name":"Biomedica : revista del Instituto Nacional de Salud","volume":"44 1","pages":"10-15"},"PeriodicalIF":0.0,"publicationDate":"2024-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11186624/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140873421","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Biomedica : revista del Instituto Nacional de Salud
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1